| Source: |
| Type: |
| custom |
| 8728- | M-Blu, | Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue |
| - | Review, | AD, | NA |
| 8729- | M-Blu, | Methylene blue modulates mitochondrial electron flow via multiple regulatory sites in isolated brain mitochondria: Implications for neurodegeneration |
| - | in-vivo, | AD, | NA |
| 2545- | M-Blu, | Reversing the Warburg Effect as a Treatment for Glioblastoma |
| - | in-vitro, | GBM, | U87MG | - | NA, | AD, | NA | - | in-vitro, | GBM, | A172 | - | in-vitro, | GBM, | T98G |
| 8494- | MAG, | Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease |
| - | in-vivo, | AD, | NA |
| 8495- | MAG, | Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats |
| - | in-vivo, | Nor, | NA |
| 8512- | MAG, | Enhanced Oral Bioavailability of the Pharmacologically Active Lignin Magnolol via Zr-Based Metal Organic Framework Impregnation |
| - | in-vivo, | Nor, | NA |
| 8510- | MAG, | Pharmacokinetic and Metabolic Profiling of Key Active Components of Dietary Supplement Magnolia officinalis Extract for Prevention against Oral Carcinoma |
| - | in-vitro, | Oral, | CAL27 | - | in-vitro, | Tong, | SCC9 | - | in-vitro, | SCC, | SCC4 |
| 8550- | Matr, | Matrine improves the hepatic microenvironment and reverses epithelial-mesenchymal transition in hepatocellular carcinoma by inhibiting the Wnt-1/β-catenin signaling pathway |
| - | vitro+vivo, | Liver, | HUH7 |
| 8638- | MBZ, | Antiparasitic agents in oncology: Innovative mechanisms, emerging evidence and clinical potential in cancer treatment |
| - | Review, | Var, | NA |
| 8646- | MBZ, | Extensive improvement of oral bioavailability of mebendazole, a brick dust, by polymer-containing SNEDDS preparation: Disruption of high crystallinity by utilizing its counter ion |
| - | in-vivo, | Var, | NA |
| 8790- | mCHEMO, | Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study |
| - | Trial, | NPC, | NA |
| 8795- | mCHEMO, | Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study |
| - | Trial, | NPC, | NA |
| 8793- | mCHEMO, | Metronomic Chemotherapy in Breast Cancer as a Strategy to Deliver More Sustainable and Less Toxic Treatments: Time to Debunk the Myth? |
| - | Review, | Var, | NA |
| 8794- | mCHEMO, | Metronomic chemotherapy and breast cancer: a critical evaluation of its role in the new landscape of therapeutics |
| - | Review, | BC, | NA |
| 8621- | MCT, | Metabolic targeting of pantothenate by medium chain fats in glioblastoma cells |
| - | Study, | GBM, | U251 |
| 3905- | MCT, | Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies |
| - | Review, | AD, | NA |
| 8714- | MeJa, | Methyl jasmonate binds to and detaches mitochondria-bound hexokinase |
| - | in-vitro, | Colon, | CT26 |
| 8757- | MeSA, | Methylseleninic acid (MSA) inhibits 17β-estradiol-induced cell growth in breast cancer T47D cells via enhancement of the antioxidative thioredoxin/ thioredoxin reductase system |
| - | in-vitro, | BC, | T47D |
| 6535- | MeSal, | Phytochemistry and Biological Profile of Gaultheria procumbens L. and Wintergreen Essential Oil: From Traditional Application to Molecular Mechanisms and Therapeutic Targets |
| - | Review, | Nor, | NA |
| 6534- | MeSal, | Volatile Constituent Analysis of Wintergreen Essential Oil and Comparison with Synthetic Methyl Salicylate for Authentication |
| - | Study, | Nor, | NA |
| 8705- | MET, | Clinical pharmacokinetics of metformin |
| - | Review, | Nor, | NA |
| 5533- | MF, | Magnetic field-induced drug permeability in liposome vesicles |
| - | in-vitro, | Nor, | NA |
| 5532- | MF, | Magnetoporation: New Method for Permeabilization of Cancerous Cells to Hydrophilic Drugs |
| - | in-vivo, | BC, | NA |
| 5241- | MF, | A review on the use of magnetic fields and ultrasound for non-invasive cancer treatment |
| - | Review, | Var, | NA |
| 2249- | MF, | Pulsed electromagnetic fields modulate energy metabolism during wound healing process: an in vitro model study |
| - | in-vitro, | Nor, | L929 |
| 2241- | MF, | Pulsed electromagnetic therapy in cancer treatment: Progress and outlook |
| - | Review, | Var, | NA |
| 8483- | MF, | Magnetic Fields in Cancer Therapy: Mechanistic Insights, Signaling Pathways, and Evidence from Clinical and In Vitro Studies |
| - | Review, | Var, | NA |
| 9292- | MF, | Pulsed Electromagnetic Field Modulates Tendon Cells Response in IL-1β-Conditioned Environment |
| - | in-vivo, | Nor, | NA |
| 9294- | MF, | Pulsed electromagnetic fields in muscle and tendon injuries: a narrative review of preclinical and clinical evidence |
| - | Review, | Nor, | NA |
| 3457- | MF, | Cellular stress response to extremely low‐frequency electromagnetic fields (ELF‐EMF): An explanation for controversial effects of ELF‐EMF on apoptosis |
| - | Review, | Var, | NA |
| 4101- | MF, | Benign Effect of Extremely Low-Frequency Electromagnetic Field on Brain Plasticity Assessed by Nitric Oxide Metabolism during Poststroke Rehabilitation |
| - | Human, | Stroke, | NA |
| 4109- | MF, | Overexpression of miR-26b-5p regulates the cell cycle by targeting CCND2 in GC-2 cells under exposure to extremely low frequency electromagnetic fields |
| - | in-vitro, | Nor, | NA |
| 4110- | MF, | Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia |
| - | Review, | Stroke, | NA |
| 4149- | MF, | Pulsed Electro-Magnetic Field (PEMF) Effect on Bone Healing in Animal Models: A Review of Its Efficacy Related to Different Type of Damage |
| - | Review, | Nor, | NA |
| 4117- | MF, | Pulsed electromagnetic fields improve the healing process of Achilles tendinopathy: a pilot study in a rat model |
| - | in-vivo, | Nor, | NA |
| 3476- | MF, | Pulsed Electromagnetic Fields Stimulate HIF-1α-Independent VEGF Release in 1321N1 Human Astrocytes Protecting Neuron-like SH-SY5Y Cells from Oxygen-Glucose Deprivation |
| - | in-vitro, | Stroke, | 1321N1 | - | in-vitro, | Park, | NA |
| 3474- | MF, | Pulsed electromagnetic fields potentiate the paracrine function of mesenchymal stem cells for cartilage regeneration |
| - | in-vitro, | Nor, | NA |
| 3473- | MF, | Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia |
| - | Human, | BPH, | NA |
| 3468- | MF, | An integrative review of pulsed electromagnetic field therapy (PEMF) and wound healing |
| - | Review, | Nor, | NA |
| 3469- | MF, | Pulsed Electromagnetic Fields (PEMF)—Physiological Response and Its Potential in Trauma Treatment |
| - | Review, | Nor, | NA |
| 3536- | MF, | Targeting Mesenchymal Stromal Cells/Pericytes (MSCs) With Pulsed Electromagnetic Field (PEMF) Has the Potential to Treat Rheumatoid Arthritis |
| - | Review, | Arthritis, | NA | - | Review, | Stroke, | NA |
| 6936- | MF, | Ex, | Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia |
| - | Trial, | BPH, | NA |
| 6940- | MF, | Meta-analysis of the effectiveness and safety of magnetic stimulation for chronic pelvic pain |
| - | Review, | BPH, | NA |
| 536- | MF, | Comparison of pulsed and continuous electromagnetic field generated by WPT system on human dermal and neural cells |
| - | in-vitro, | Nor, | SH-SY5Y | - | in-vitro, | GBM, | T98G | - | in-vitro, | Nor, | HDFa |
| 524- | MF, | Inhibition of Angiogenesis Mediated by Extremely Low-Frequency Magnetic Fields (ELF-MFs) |
| - | vitro+vivo, | PC, | MS-1 | - | vitro+vivo, | PC, | HUVECs |
| 527- | MF, | Effects of Fifty-Hertz Electromagnetic Fields on Granulocytic Differentiation of ATRA-Treated Acute Promyelocytic Leukemia NB4 Cells |
| - | in-vitro, | AML, | APL NB4 |
| 533- | MF, | Effects of extremely low-frequency magnetic fields on human MDA-MB-231 breast cancer cells: proteomic characterization |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
| 486- | MF, | mTOR Activation by PI3K/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes |
| - | in-vitro, | Nor, | HaCaT |
| 196- | MF, | Mechanism for action of electromagnetic fields on cells |
| - | in-vitro, | Nor, | NA |
| 197- | MF, | A mechanism for action of oscillating electric fields on cells |
| - | Study, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:767 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid